Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 53: 2020-2023, 2007; 10.1373/clinchem.2007.091157
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow 091157.Supplemental Data
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boissinot, K.
Right arrow Articles by Bergeron, M. G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Boissinot, K.
Right arrow Articles by Bergeron, M. G.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Point-of-Care Testing
(Clinical Chemistry. 2007;53:2020-2023.)
© 2007 American Association for Clinical Chemistry, Inc.


Abstracts of Oak Ridge Posters

Rapid Exonuclease Digestion of PCR-Amplified Targets for Improved Microarray Hybridization

Karel Boissinot1,2, Ann Huletsky1,2, Régis Peytavi1,2, Sophie Turcotte1, Véronique Veillette1, Maurice Boissinot1,2, François J. Picard1,2, Eric A. Martel1 and Michel G. Bergeron1,2,a

(1 Centre de Recherche en Infectiologie de l’Université Laval, Centre Hospitalier Universitaire de Québec (Pavillon CHUL), Quebec City, Québec, Canada; 2 Division de Microbiologie, Faculté de Médecine, Université Laval, Quebec City, Québec, Canada;

aaddress correspondence to this author at: Centre de Recherche en Infectiologie de l’Université Laval, Centre Hospitalier Universitaire de Québec, Pavillon CHUL, 2705 Laurier Blvd., Quebec City, Québec, G1V 4G2 Canada; fax 418-654-2715, e-mail Michel.G.Bergeron@crchul.ulaval.ca)

The first 300 words of the full text of this article appear below.

Hybridization of double-stranded DNA with nucleic acid probes is hampered by competition between the complementary nontarget strand and the probe (1). This competition is stronger with surface-bound probes that expose a target strand with a long dangling end toward the media(2)(3). This situation is more problematic in infectious disease diagnostics, which requires high sensitivity, sometimes as low as 1 genome copy. Microarray integration into microfluidic systems results in increased speed and sensitivity while allowing automation of the whole hybridization process(4) and could lead to the development of point-of-care diagnostic devices. Actual limitations of diagnostic microarrays include the design of ultrasensitive capture probes that are highly specific and discriminant. Some techniques have been developed to produce single-stranded DNA targets for sequencing and hybridization, but these methods may necessitate additional steps or modification of the target strand or have poor sensitivities(5)(6)(7)(8). Degradation of the complementary strand can alleviate competition problems and allow more flexible probe design for the target strand. Therefore, we developed a simple 5-min method for rapid single-step selective digestion of the complementary strand with lambda exonuclease, which leads to increased hybridization signals and improved differentiation of single-nucleotide polymorphisms (SNPs) on DNA microarrays.

Cy3-labeled primers were used to generate the target strands, and phosphorylated primers were used to generate the complementary strands. Nonphosphorylated primers were also used to verify the protection provided by the Cy3-labeled primers. All oligonucleotides were purchased from Integrated DNA Technologies. Purified genomic DNA (1 ng) from Neisseria meningitidis (ATCC-13077), Listeria monocytogenes (CCRI-4862), and Candida krusei (ATCC-28870) were PCR-amplified with a PTC-200 thermocycler (Bio-Rad Laboratories; 1 min at 94 °C, then 40 cycles of 1 s at 95 °C for the denaturation step, 10 s at 60 °C for the annealing . . . [Full Text of this Article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Association for Clinical Chemistry.